Go Deep
Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,878 | 12.5 | 0.81 | 0.07 | 1,961.38 |
| Oct 2026 | 22,961 | 12.6 | 0.81 | 0.07 | 1,963.67 |
| Oct 2026 | 23,017 | 12.5 | 0.80 | 0.07 | 1,935.00 |
Mochida Pharmaceutical Co., Ltd. Quarterly Results
| Line Item | Jun 2026 | Jun 2025 |
|---|---|---|
| EPS | 89.8 | 53.4 |
Mochida Pharmaceutical Co., Ltd. Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 116,951,000,000.0 | 105,159,000,000.0 | 102,885,000,000.0 | 103,261,000,000.0 | — |
| Net Profit | 7,903,000,000.0 | 5,685,000,000.0 | 4,547,000,000.0 | 6,649,000,000.0 | — |
| EPS | 223.0 | 160.4 | 126.8 | 178.9 | — |
Mochida Pharmaceutical Co., Ltd. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 182,720,000,000.0 | 160,121,000,000.0 | 158,800,000,000.0 | 158,831,000,000.0 | — |
| Total Liabilities | 42,396,000,000.0 | 29,428,000,000.0 | 30,835,000,000.0 | 32,058,000,000.0 | — |
| Total Equity | 140,324,000,000.0 | 130,693,000,000.0 | 127,965,000,000.0 | 126,773,000,000.0 | — |
Owes vs Owns
Mochida Pharmaceutical Co., Ltd. owed ¥0.23 for every ¥1 it owned in Mar 2026, up from ¥0.20 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.23× | 0.18× | 0.19× | 0.20× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Mochida Pharmaceutical Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 17.0%Receivables 20.0%Inventory 19.8%Fixed assets (tangible) 8.9%Intangible assets 0.6%Long-term investments 21.5%Other assets 12.3%
How it's funded — Mar 2026
Long-term debt 5.5%Payables 5.4%Other liabilities 12.4%Shareholders' equity 76.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 31,057.0 | 51,150.0 | 46,789.0 | 60,509.0 |
| Receivables | 36,478.0 | 31,617.0 | 34,838.0 | 27,806.0 |
| Inventory | 36,121.0 | 33,295.0 | 30,278.0 | 24,404.0 |
| Fixed assets (tangible) | 16,302.0 | 15,940.0 | 15,874.0 | 15,049.0 |
| Intangible assets | 1,121.0 | 920.0 | 721.0 | 797.0 |
| Long-term investments | 39,228.0 | 15,022.0 | 16,116.0 | 14,246.0 |
| Other assets | 22,413.0 | 12,177.0 | 14,184.0 | 16,020.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 10,000.0 | 0.0 | 0.0 | 0.0 |
| Payables | 9,779.0 | 7,419.0 | 10,975.0 | 9,047.0 |
| Other liabilities | 22,617.0 | 22,009.0 | 19,860.0 | 23,011.0 |
| Shareholders' equity | 140,324.0 | 130,693.0 | 127,965.0 | 126,773.0 |
| Net tangible assets | 139,203.0 | 129,773.0 | 127,244.0 | 125,976.0 |
Mochida Pharmaceutical Co., Ltd. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -7,350,000,000.0 | 9,354,000,000.0 | -7,480,000,000.0 | 7,297,000,000.0 | — |
| Investing Activities | -16,848,000,000.0 | 17,355,000,000.0 | 74,000,000.0 | -2,949,000,000.0 | — |
| Financing Activities | 7,033,000,000.0 | -2,865,000,000.0 | -6,393,000,000.0 | -6,884,000,000.0 | — |